Table 2.
Summary for the detected alterations of the Tslc1 (tumor suppressor in lung cancer 1) and Dal‐1 (differentially expressed in adenocarcinoma of the lung) genes
| Samples | Tslc1 | Dal‐1 | |||
|---|---|---|---|---|---|
| mRNA expression | DNA methylation | Protein abnormality | mRNA expression | DNA methylation | |
| HCC1 | Expressed | Unmethylated | ND | Expressed | Unmethylated |
| HCC2 | Expressed | – | – | Expressed | – |
| HCC3 | Expressed | – | – | Expressed | – |
| HCC4 | Reduced | Methylated | Reduced | Expressed | – |
| HCC5 | Reduced | Methylated | Reduced | Expressed | Unmethylated |
| HCC6 | Expressed | – | ND | Expressed | – |
| HCC7 | Expressed | – | – | Expressed | – |
| HCC8 | Reduced | Methylated | Reduced | Expressed | – |
| HCC9 | Expressed | – | – | Expressed | – |
| HCC10 | Expressed | – | – | Expressed | – |
–, not evaluated; HCC, hepatocellular carcinoma; ND, not detected.